MYX
MAYNE PHARMA LTD ORDINARYMayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
MYX
MYX
MAYNE PHARMA LTD ORDINARY
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 2.43% | — |
| 10 July | 2.49% | — |
| 9 July | 2.52% | — |
| 8 July | 2.53% | — |
| 7 July | 2.55% | — |
| 6 July | 2.57% | — |
| 3 July | 2.58% | — |
| 2 July | 2.58% | — |
| 1 July | 2.60% | — |
Mayne Pharma LTD (MYX) Short Interest Summary
Mayne Pharma LTD (MYX) currently has 2.43% of its shares sold short (2.0 million shares, worth approximately $5.8 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes MYX the #136 most shorted stock on the ASX most shorted list. Short interest in MYX is down 0.14% over the past week and down 0.39% over the past month. MYX is part of the Health Care sector on the ASX.
Recent MYX Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 2.43% | 2.0M | $2.83 |
| 10 July 2026 | 2.49% | 2.0M | $2.87 |
| 9 July 2026 | 2.52% | 2.0M | $2.84 |
| 8 July 2026 | 2.53% | 2.1M | $2.86 |
| 7 July 2026 | 2.55% | 2.1M | $2.88 |
| 6 July 2026 | 2.57% | 2.1M | $2.79 |
| 3 July 2026 | 2.58% | 2.1M | $2.76 |
| 2 July 2026 | 2.58% | 2.1M | $2.78 |
| 1 July 2026 | 2.60% | 2.1M | $2.91 |
| 30 June 2026 | 2.60% | 2.1M | $2.79 |
MYX Short Selling — Frequently Asked Questions
What is Mayne Pharma LTD (MYX)'s current short interest?
Mayne Pharma LTD (MYX) currently has a short interest of 2.43% of total shares outstanding. This means 2.43% of MYX's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is MYX heavily shorted on the ASX?
MYX has a relatively low short interest of 2.43%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for MYX investors?
Short interest in MYX shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 2.43%, MYX's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this MYX short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for MYX.